Common Stock, Shares, Outstanding of NeuroSense Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: shares
Description: Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary: NeuroSense Therapeutics Ltd. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2022 to 30 Jun 2025.
NeuroSense Therapeutics Ltd. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 24,602,405, a 36% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Shares, Outstanding, Quarterly (shares)

Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NeuroSense Therapeutics Ltd. Quarterly Common Stock, Shares, Outstanding (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	24,602,405	+6,547,399	+36%	30 Jun 2025	6-K	01 Aug 2025	2025	Q2
Q4 2024	23,228,941	+7,849,899	+51%	31 Dec 2024	6-K	01 Aug 2025	2025	Q2
Q2 2024	18,055,006			30 Jun 2024	6-K	30 Sep 2024	2024	Q2
Q4 2023	15,379,042	+3,597,079	+31%	31 Dec 2023	20-F	07 Apr 2025	2024	FY
Q4 2022	11,781,963			31 Dec 2022	6-K	17 Jun 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.